Repurposing of rabeprazole as an anti-Trypanosoma cruzi drug that targets cellular triosephosphate isomerase

Trypanosoma cruzi is the causative agent of American trypanosomiasis, which mainly affects populations in Latin America. Benznidazole is used to control the disease, with severe effects in patients receiving this chemotherapy. Previous studies have demonstrated the inhibition of triosephosphate isom...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Torres, Itzhel, De la Mora-De la Mora, Ignacio, López-Velázquez, Gabriel, Cabrera, Nallely, Flores-López, Luis Antonio, Becker, Ingeborg, Herrera-López, Juliana, Hernández, Roberto, Pérez-Montfort, Ruy, Enríquez-Flores, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351538/
https://www.ncbi.nlm.nih.gov/pubmed/37401012
http://dx.doi.org/10.1080/14756366.2023.2231169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351538/
https://www.ncbi.nlm.nih.gov/pubmed/37401012
http://dx.doi.org/10.1080/14756366.2023.2231169

Ejemplares similares